- Home
- CCK vs MEDP Comparison
CCK vs MEDP Comparison
Compare CCK & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCK
- MEDP
- Stock Information
- Founded
- CCK 1906
- MEDP 1992
- Country
- CCK United States
- MEDP United States
- Employees
- CCK N/A
- MEDP N/A
- Industry
- CCK Containers/Packaging
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- CCK Industrials
- MEDP Health Care
- Exchange
- CCK Nasdaq
- MEDP Nasdaq
- Market Cap
- CCK 10.5B
- MEDP 10.5B
- IPO Year
- CCK N/A
- MEDP 2016
- Fundamental
- Price
- CCK $87.30
- MEDP $340.22
- Analyst Decision
- CCK Strong Buy
- MEDP Buy
- Analyst Count
- CCK 14
- MEDP 10
- Target Price
- CCK $104.85
- MEDP $389.89
- AVG Volume (30 Days)
- CCK 1.4M
- MEDP 310.8K
- Earning Date
- CCK 02-05-2025
- MEDP 02-10-2025
- Dividend Yield
- CCK 1.14%
- MEDP N/A
- EPS Growth
- CCK N/A
- MEDP 42.23
- EPS
- CCK 3.55
- MEDP 12.63
- Revenue
- CCK $11,801,000,000.00
- MEDP $2,109,054,000.00
- Revenue This Year
- CCK $3.45
- MEDP $7.54
- Revenue Next Year
- CCK $2.73
- MEDP $11.55
- P/E Ratio
- CCK $24.64
- MEDP $27.15
- Revenue Growth
- CCK N/A
- MEDP 11.84
- 52 Week Low
- CCK $70.84
- MEDP $302.01
- 52 Week High
- CCK $98.46
- MEDP $459.77
- Technical
- Relative Strength Index (RSI)
- CCK 49.90
- MEDP 47.17
- Support Level
- CCK $87.49
- MEDP $336.78
- Resistance Level
- CCK $89.56
- MEDP $347.58
- Average True Range (ATR)
- CCK 2.20
- MEDP 12.05
- MACD
- CCK -0.05
- MEDP -0.79
- Stochastic Oscillator
- CCK 35.80
- MEDP 34.48
About CCK Crown Holdings Inc.
Crown Holdings is one of the world's largest producers of metal packaging. The company manufactures beverage cans, metal food cans, and closures as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.